Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Postacute Sequelae of Sars-CoV-2”

3 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 3 of 3 results

Early research (Phase 1)Not Yet RecruitingNCT07388550
What this trial is testing

Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute Sequelae of SARS-CoV-2 (PD1-PASC I)

Who this might be right for
Post-Acute COVID-19 Syndrome
National Institute of Neurological Disorders and Stroke (NINDS) 15
Not applicableStudy completedNCT05200858
What this trial is testing

Transcutaneous Electrical Nerve Stimulation (TENS) in Patients With Postacute Sequelae of Sars-CoV-2

Who this might be right for
Postacute Sequelae of Sars-CoV-2Post-Acute COVID-19 SyndromeWidespread Chronic Pain+2 more
Baylor College of Medicine 30
Testing effectiveness (Phase 2)Study completedNCT05497089
What this trial is testing

Temelimab as a Disease Modifying Therapy in Patients With Neuropsychiatric Symptoms in Post-COVID 19 or PASC Syndrome

Who this might be right for
Post-COVID-19 Syndrome
GeNeuro SA 203